Amoxicillin And Beta-Lactamase Inhibitor
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
5.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Ampicillin
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
100.00 |
|
20 |
No use |
85.00 |
|
20 |
|
Cefoxitin
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
5.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Ceftiofur
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Ceftriaxone
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Chloramphenicol
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Ciprofloxacin
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Gentamicin
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Nalidixic Acid
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Streptomycin
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
5.00 |
|
20 |
No use |
10.00 |
|
20 |
|
Sulfafurazole
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Tetracycline
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
70.00 |
|
20 |
No use |
60.00 |
|
20 |
|
Sulfamethoxazole And Trimethoprim
/
|
Escherichia coli
|
See: Table 7 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Chloramphenicol
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Ciprofloxacin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Daptomycin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
15.00 |
|
20 |
No use |
10.00 |
|
20 |
|
Erythromycin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
15.00 |
|
20 |
No use |
15.00 |
|
20 |
|
Gentamicin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Kanamycin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Lincomycin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
85.00 |
|
20 |
No use |
95.00 |
|
20 |
|
Linezolid
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Nitrofurantoin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Quinupristin And Dalfopristin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Streptomycin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
5.00 |
|
20 |
|
Tetracycline
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
65.00 |
|
20 |
No use |
60.00 |
|
20 |
|
Tigecycline
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|
Tylosin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
10.00 |
|
20 |
No use |
15.00 |
|
20 |
|
Vancomycin
/
|
Enterococcus Not Specified
|
See: Table 9 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Zinc use |
0.00 |
|
20 |
No use |
0.00 |
|
20 |
|